Skip to content

US · IRD

Opus Genetics, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Durham, NC 27713

Price · as of 2026-09-03

$4.60

Market cap 312.1M

Price history

Weekly OHLC price history for IRD, USD per share
WeekOpenHighLowCloseVolume
Sep 23, 2024 – Sep 27, 2024$1.37$1.38$1.25$1.290
Sep 30, 2024 – Oct 4, 2024$1.32$1.35$1.25$1.320
Oct 7, 2024 – Oct 11, 2024$1.33$1.39$1.21$1.220
Oct 14, 2024 – Oct 18, 2024$1.22$1.33$1.21$1.320
Oct 21, 2024 – Oct 25, 2024$1.35$1.36$1.07$1.170
Oct 28, 2024 – Nov 1, 2024$1.20$1.36$1.16$1.180
Nov 4, 2024 – Nov 8, 2024$1.17$1.20$1.09$1.120
Nov 11, 2024 – Nov 15, 2024$1.13$1.18$0.97$1.060
Nov 18, 2024 – Nov 22, 2024$1.05$1.07$0.85$1.010
Nov 25, 2024 – Nov 29, 2024$1.08$1.12$1.02$1.110
Dec 2, 2024 – Dec 6, 2024$1.13$1.21$1.05$1.110
Dec 9, 2024 – Dec 13, 2024$1.11$1.22$1.02$1.020
Dec 16, 2024 – Dec 20, 2024$1.02$1.10$0.81$0.980
Dec 23, 2024 – Dec 27, 2024$1.00$1.18$0.95$1.180
Dec 30, 2024 – Jan 3, 2025$1.09$1.37$1.08$1.350
Jan 6, 2025 – Jan 10, 2025$1.35$1.56$1.31$1.420
Jan 13, 2025 – Jan 17, 2025$1.42$1.43$1.12$1.130
Jan 20, 2025 – Jan 24, 2025$1.12$1.22$1.07$1.140
Jan 27, 2025 – Jan 31, 2025$1.14$1.21$1.05$1.110
Feb 3, 2025 – Feb 7, 2025$1.09$1.27$1.06$1.150
Feb 10, 2025 – Feb 14, 2025$1.14$1.18$1.10$1.130
Feb 17, 2025 – Feb 21, 2025$1.14$1.19$1.08$1.100
Feb 24, 2025 – Feb 28, 2025$1.10$1.12$1.00$1.030
Mar 3, 2025 – Mar 7, 2025$1.07$1.10$0.92$1.000
Mar 10, 2025 – Mar 14, 2025$0.98$1.00$0.88$0.930
Mar 17, 2025 – Mar 21, 2025$0.93$1.29$0.93$1.260
Mar 24, 2025 – Mar 28, 2025$1.16$1.28$0.96$1.010
Mar 31, 2025 – Apr 4, 2025$0.97$1.14$0.87$0.890
Apr 7, 2025 – Apr 11, 2025$0.89$0.90$0.65$0.710
Apr 14, 2025 – Apr 17, 2025$0.70$0.89$0.70$0.760
Apr 21, 2025 – Apr 25, 2025$0.76$0.84$0.71$0.840
Apr 28, 2025 – May 2, 2025$0.85$1.03$0.81$0.950
May 5, 2025 – May 9, 2025$0.95$1.04$0.92$0.950
May 12, 2025 – May 16, 2025$0.94$1.07$0.93$1.020
May 19, 2025 – May 23, 2025$1.04$1.09$0.96$1.020
May 26, 2025 – May 30, 2025$1.02$1.04$0.95$0.990
Jun 2, 2025 – Jun 6, 2025$1.69$1.75$0.93$1.040
Jun 9, 2025 – Jun 13, 2025$1.07$1.08$0.95$0.970
Jun 16, 2025 – Jun 20, 2025$0.97$0.98$0.91$0.950
Jun 23, 2025 – Jun 27, 2025$0.96$1.05$0.91$0.980
Jun 30, 2025 – Jul 3, 2025$0.94$1.03$0.90$1.000
Jul 7, 2025 – Jul 11, 2025$1.00$1.15$0.98$1.130
Jul 14, 2025 – Jul 18, 2025$1.13$1.18$1.08$1.130
Jul 21, 2025 – Jul 25, 2025$1.17$1.23$1.12$1.180
Jul 28, 2025 – Aug 1, 2025$1.21$1.23$1.06$1.070
Aug 4, 2025 – Aug 8, 2025$1.10$1.14$1.05$1.070
Aug 11, 2025 – Aug 15, 2025$1.07$1.24$1.04$1.200
Aug 18, 2025 – Aug 22, 2025$1.23$1.23$1.10$1.150
Aug 25, 2025 – Aug 29, 2025$1.14$1.27$1.13$1.220
Sep 1, 2025 – Sep 5, 2025$1.28$1.35$1.22$1.270
Sep 8, 2025 – Sep 12, 2025$1.32$1.47$1.28$1.380
Sep 15, 2025 – Sep 19, 2025$1.36$1.59$1.35$1.520
Sep 22, 2025 – Sep 26, 2025$1.56$1.83$1.52$1.820
Sep 29, 2025 – Oct 3, 2025$1.83$1.92$1.50$1.880
Oct 6, 2025 – Oct 10, 2025$1.91$2.16$1.85$1.960
Oct 13, 2025 – Oct 17, 2025$1.99$2.09$1.86$1.870
Oct 20, 2025 – Oct 24, 2025$1.93$2.04$1.89$1.990
Oct 27, 2025 – Oct 31, 2025$1.97$2.30$1.90$2.300
Nov 3, 2025 – Nov 7, 2025$2.32$2.37$1.86$2.000
Nov 10, 2025 – Nov 14, 2025$2.03$2.03$1.78$1.880
Nov 17, 2025 – Nov 21, 2025$1.85$2.05$1.70$1.910
Nov 24, 2025 – Nov 28, 2025$1.94$2.15$1.92$2.130
Dec 1, 2025 – Dec 5, 2025$2.11$2.29$1.97$2.270
Dec 8, 2025 – Dec 12, 2025$2.28$2.59$2.21$2.360
Dec 15, 2025 – Dec 19, 2025$2.37$2.42$1.92$2.000
Dec 22, 2025 – Dec 26, 2025$2.02$2.12$1.96$2.020
Dec 29, 2025 – Jan 2, 2026$2.00$2.33$1.93$2.120
Jan 5, 2026 – Jan 9, 2026$2.16$2.17$1.89$1.930
Jan 12, 2026 – Jan 16, 2026$1.96$2.26$1.88$2.100
Jan 19, 2026 – Jan 23, 2026$2.07$2.58$2.07$2.560
Jan 26, 2026 – Jan 30, 2026$2.57$3.05$2.28$2.310
Feb 2, 2026 – Feb 6, 2026$2.26$3.08$2.21$3.010
Feb 9, 2026 – Feb 13, 2026$3.01$3.70$3.01$3.640
Feb 16, 2026 – Feb 20, 2026$3.66$3.97$3.32$3.390
Feb 23, 2026 – Feb 27, 2026$3.38$4.17$3.29$4.160
Mar 2, 2026 – Mar 6, 2026$4.08$5.10$3.83$4.890
Mar 9, 2026 – Mar 13, 2026$4.87$5.30$4.68$5.030
Mar 16, 2026 – Mar 20, 2026$5.08$5.28$4.33$4.390
Mar 23, 2026 – Mar 27, 2026$4.43$4.79$4.32$4.350
Mar 30, 2026 – Apr 2, 2026$4.57$4.96$4.25$4.550
Apr 6, 2026 – Apr 10, 2026$4.61$5.73$4.43$5.360
Apr 13, 2026 – Apr 17, 2026$5.37$5.81$5.16$5.750
Apr 20, 2026 – Apr 24, 2026$5.68$5.70$4.94$5.230
Apr 27, 2026 – May 1, 2026$5.24$5.43$4.66$5.140
May 4, 2026 – May 8, 2026$5.10$5.40$4.85$4.990
May 11, 2026 – May 15, 2026$5.00$5.23$4.69$4.800
May 18, 2026 – May 22, 2026$4.80$4.81$4.19$4.260
May 25, 2026 – May 29, 2026$4.30$4.55$3.90$4.360
Jun 1, 2026 – Jun 5, 2026$4.40$4.68$3.88$4.030
Jun 8, 2026 – Jun 12, 2026$4.11$4.24$3.83$4.040
Jun 15, 2026 – Jun 18, 2026$4.12$4.26$3.80$4.070
Jun 22, 2026 – Jun 26, 2026$4.07$4.29$3.62$4.000
Jun 29, 2026 – Jul 2, 2026$4.03$4.38$3.93$4.230
Jul 6, 2026 – Jul 10, 2026$4.24$4.39$3.80$3.920
Jul 13, 2026 – Jul 17, 2026$3.90$3.91$3.18$3.270
Jul 20, 2026 – Jul 24, 2026$3.22$3.37$2.82$3.080
Jul 27, 2026 – Jul 31, 2026$3.08$3.88$3.08$3.710
Aug 3, 2026 – Aug 7, 2026$3.72$3.96$3.53$3.660
Aug 10, 2026 – Aug 14, 2026$3.63$3.99$3.56$3.610
Aug 17, 2026 – Aug 21, 2026$3.60$4.33$3.55$4.050
Aug 24, 2026 – Aug 28, 2026$4.02$4.42$3.63$3.690
Aug 31, 2026 – Sep 3, 2026$3.71$4.83$3.51$4.600

Valuation

MetricValueUpside
IC Value$2.01-56%
P/E-63.11
P/B203.92
P/S220.47
EV/EBITDA-64.17
PEG
P/TBV203.92

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for IRD, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019$8.92
2020$7.95
2021$3.46
2022$3.40
2023$1.99
2024$1.00$34.78
2025$5.03$15.26

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Opus Genetics, Inc.

        Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

        CEO
        George Magrath
        Employees
        28
        Beta
        0.56

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for IRD: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        IRDOpus Genetics, Inc.$3.66312.1M$15.26+317%-63.11203.92220.47-64.17203.92100.00%-271.90%-349.33%-449.36%144.72%-113.86%0.00-26.336.436.200.94-62.79%29.15%37.84%-1.13%-4.53132.18%0.00%0.00%0.48%-79.92-87.50217.2947.32
        ABOSAcumen Pharmaceuticals, I…$2.24161.79M-1.632.81-0.96-9.622.810.00%0.00%0.00%-96.20%-997.16%-67.07%0.44-29.324.073.920.1916.96%34.09%-58.39%-3.85-931.08%0.00%0.00%8.50%-0.91-0.97-5.25
        AGENAgenus Inc.$7.78323.98M$6.06-22%-0.40-0.340.816.82-0.3129.63%-18.00%0.10%77.75%19.47%-102.53%-1.24-0.370.410.015.34-99.97%10.37%0.00%-172.38%-0.49150.50%0.00%0.00%0.09%-20.63-2.673.71-14.17
        ALECAlector, Inc.$1.49165.43M$14.39+865%-1.597.3910.77-0.05-12.197.3954.09%-692.83%-679.16%-181.56%67.31%-37.54%1.183.833.680.2213.01%-79.07%-20.37%-81.23%-2.6584.98%0.00%0.00%17.24%-0.05-0.040.32-4.89
        CGTXCognition Therapeutics, I…$1.0694.87M-3.252.23-1.732.230.00%0.00%0.00%-88.60%1301.36%-59.75%0.02-3676.853.453.361.56-62.35%-13.66%-32.18%-1.77669.43%0.00%0.00%15.68%-0.84-1.64-4.92
        HURATuHURA Biosciences, Inc.$2.09133.1M-3.034.35-3.008.930.00%0.00%0.00%-169.18%-315.57%-127.02%0.03-50.850.780.610.10-48.09%87.37%-30.42%-4.67-274.97%0.01%0.00%0.01%-2.77-3.18-2.61
        INOInovio Pharmaceuticals, I…$0.6846.78M$12.28+1,713%-0.923.231191.12-0.353.23100.00%-132871.32%-130000.00%-183.47%447.62%-90.61%0.391.401.340.43-54.18%-69.99%-14.97%-114.24%-2.03458.41%0.00%0.00%0.00%-0.33-0.32439.02-36.84
        MCRBSeres Therapeutics, Inc.$5.0148.47M13.421.7396.9011.561.73-423.83%-11910.14%721.93%19.64%-120.44%4.10%1.882.562.393.78-103.39%-100.58%1.13%0.061.11%0.00%0.00%30.93%-1.21131.39144.05-11.34
        SEERSeer, Inc.$2.19120.41M$11.52+426%-1.410.406.450.810.4049.67%-483.85%-456.60%-25.08%-72.83%-22.21%0.0912.8412.230.33-7.91%15.57%-6.94%-44.47%-2.83-43.18%0.00%0.00%18.31%0.751.26-3.61-0.57
        TILInstil Bio, Inc.$7.2649.24M-0.770.48-0.990.480.00%0.00%0.00%-50.39%-39.79%-30.56%0.75-9.0839.5315.89-1.21-6.06%-44.26%-66.48%-7.56-27.54%0.00%0.00%0.00%-1.21-1.75-4.39
        VTGNVistaGen Therapeutics, In…$0.3012.19M$18.27+6,052%-0.300.5816.200.33-3.080.58100.00%-5683.69%-5491.33%-131.59%827.99%-104.86%0.033.673.550.429.58%161.11%57.46%-323.87%-5.19764.40%0.00%0.00%0.00%0.330.36-18.75-16.85

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.01 ÷ $4.60) − 1 = -56.3% (IC, example).